Inhibition of CD38 shows anti-leukemic Activity in the acute myeloid Leukemia

被引：0
|
作者：
Farber, Meike [1 ]
Arnold, Lucas [1 ]
Chen, Yiyang [1 ]
Moellmann, Michael [1 ]
Carpinteiro, Alexander [1 ]
Duehrsen, Ulrich [1 ]
Hanoun, Maher [1 ]
机构：
[1] Univ Klinikum Essen, Hamatol, Essen, Germany
来源：
INTERNIST | 2019年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
YIA08
引用
收藏
页码：S7 / S8
页数：2
相关论文
共 50 条
  • [21] Anti-Leukemic Activity of Shikonin: Role of ERP57 in Shikonin Induced Apoptosis in Acute Myeloid Leukemia
    Trivedi, Rachana
    Mueller, Gerhard A.
    Rathore, Manohar S.
    Mishra, Durga P.
    Dihazi, Hassan
    [J]. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2016, 39 (02) : 604 - 616
  • [22] Anti-leukemic Activity of AIU2008 in FLT3-ITD-positive Acute Myeloid Leukemia
    Kim, Hyo Jeong
    Ryu, Hwani
    Choi, Hyun-Kyung
    Song, Jie-Young
    Hwang, Sang-Gu
    Ahn, Jiyeon
    [J]. ANTICANCER RESEARCH, 2021, 41 (02) : 731 - 737
  • [23] Venetoclax Synergistically Enhances the Anti-leukemic Activity of Vosaroxin Against Acute Myeloid Leukemia Cells Ex Vivo
    Liu, Fangbing
    Knight, Tristan
    Su, Yongwei
    Edwards, Holly
    Wang, Guan
    Wang, Yue
    Taub, Jeffrey W.
    Lin, Hai
    Sun, Liwei
    Ge, Yubin
    [J]. TARGETED ONCOLOGY, 2019, 14 (03) : 351 - 364
  • [24] Pan-RAF Inhibition Shows Anti-Leukemic Activity in RAS-Mutant Acute Myeloid Leukemia Cells and Potentiates the Effect of Sorafenib in Cells with FLT3 Mutation
    Khoury, Joseph D.
    Tashakori, Mehrnoosh
    Yang, Hong
    Loghavi, Sanam
    Wang, Ying
    Wang, Jing
    Piya, Sujan
    Borthakur, Gautam
    [J]. CANCERS, 2020, 12 (12) : 1 - 13
  • [25] COMBINED INHIBITION OF HEDGEHOG AND FLT3 SIGNALLING LEADS TO EFFECTIVE ANTI-LEUKEMIC EFFECTS IN ACUTE MYELOID LEUKEMIA
    Latuske, E.
    Stamm, H.
    Klokow, M.
    Vohwinkel, G.
    Kebenko, M.
    Bokemeyer, C.
    Juecker, M.
    Fiedler, W.
    Wellbrock, J.
    [J]. HAEMATOLOGICA, 2015, 100 : 354 - 355
  • [26] Addition of the PARP Inhibitor, Talazoparib, to Gemtuzumab Ozogamicin Significantly Enhances Anti-Leukemic Activity in Human CD33+Acute Myeloid Leukemia
    Portwood, Scott M.
    Cantella, Marianna C.
    Cronin, Tara L.
    Wang, Eunice S.
    [J]. BLOOD, 2019, 134
  • [27] The Sesquiterpene Lactone Dehydroleucodine Shows Potent Anti-Leukemic Activity
    Ordonez, P. E.
    Sharma, K.
    Martin, A. B.
    Reynolds, W. F.
    Enriquez, R. G.
    Malagon, O.
    Jones, D. E.
    Guzman, M. L.
    Compadre, C. M.
    [J]. PLANTA MEDICA, 2013, 79 (10) : 829 - 829
  • [28] A COMBINED IMMUNOSTIMULATORY AND IMMUNOINHIBITORY SIRNA WITH ANTI-LEUKEMIC PROPERTIES IN A RAT MODEL OF ACUTE MYELOID LEUKEMIA
    Iversen, P. O.
    Semaeva, E.
    Sorensen, D. R.
    Wiig, H.
    Sioud, M.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : S30 - S30
  • [29] Tyrosine kinase inhibitors for the treatment of acute myeloid leukemia: Delineation of anti-leukemic mechanisms of action
    Lainey, Elodie
    Thepot, Sylvain
    Bouteloup, Cyrielle
    Sebert, Marie
    Ades, Lionel
    Tailler, Maximilien
    Gardin, Claude
    de Batton, Stephane
    Baruchel, Andre
    Fenaux, Pierre
    Kraemer, Guido
    Boehrer, Simone
    [J]. BIOCHEMICAL PHARMACOLOGY, 2011, 82 (10) : 1457 - 1466
  • [30] APR-246 exhibits anti-leukemic activity and synergism with conventional chemotherapeutic drugs in acute myeloid leukemia cells
    Ali, Dina
    Jonsson-Videsater, Kerstin
    Deneberg, Stefan
    Bengtzen, Sofia
    Nahi, Hareth
    Paul, Christer
    Lehmann, Soren
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2011, 86 (03) : 206 - 215
12345